Back
Merck KGaA Vs. TG Therapeutics, Inc. Industry Stock Comparison
Sell
22
MKGAF
Merck KGaA
Last Price:
$128.10
Seasonality Move:
2.15%
Sell
49
TGTX
TG Therapeutics, Inc.
Last Price:
$33.52
Seasonality Move:
9.24%
Sell
22
Merck KGaA (MKGAF)
is a Sell
Is Merck KGaA a Buy, Sell or Hold?
-
The current Merck KGaA [MKGAF] share price is $128.10. The Score for MKGAF is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
MKGAF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
TG Therapeutics, Inc. (TGTX)
is a Sell
Is TG Therapeutics, Inc. a Buy, Sell or Hold?
-
The current TG Therapeutics, Inc. [TGTX] share price is $33.57. The Score for TGTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
TGTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MKGAF Stock Price Chart
What is Merck KGaA's stock price today?
-
The Merck KGaA share price today is $128.10Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MKGAF is experiencing buying pressure, which is a positive indicator for future bullish movement.
TGTX Stock Price Chart
What is TG Therapeutics, Inc.'s stock price today?
-
The TG Therapeutics, Inc. share price today is $33.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TGTX is experiencing slight selling pressure.
MKGAF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 33.01 | Buy |
| Relative Strength Index (14 RSI): | 46.44 | Sell |
| Chaikin Money Flow: | 284 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.74 - 139.62) | Sell |
| Bollinger Bands (100): | (131.02 - 151.38) | Sell |
TGTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 66.68 | Buy |
| Chaikin Money Flow: | -933024 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
MKGAF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.6 | Buy |
| 20-day SMA: | 126.78 | Buy |
| 50-day SMA: | 140.9 | Sell |
| 200-day SMA: | 136.16 | Sell |
| 8-day EMA: | 119.48 | Buy |
| 20-day EMA: | 87.69 | Buy |
| 50-day EMA: | 47.79 | Buy |
| 200-day EMA: | 14.17 | Buy |
TGTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.82 | Buy |
| 20-day SMA: | 30.25 | Buy |
| 50-day SMA: | 29.92 | Buy |
| 200-day SMA: | 32.07 | Buy |
| 8-day EMA: | 32 | Buy |
| 20-day EMA: | 30.88 | Buy |
| 50-day EMA: | 30.32 | Buy |
| 200-day EMA: | 31.3 | Buy |
Merck KGaA Earnings Growth & MKGAF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
TG Therapeutics, Inc. Earnings Growth & TGTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.22 per share.
Merck KGaA Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
TG Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||